NCT04662021 is a NA clinical trial of Aerobic Exercises in Anxiety Depression Disorder, sponsored by Cairo University.

Who is sponsoring NCT04662021?

NCT04662021 is sponsored by Cairo University.

What drugs are being tested in NCT04662021?

Interventions in NCT04662021: Aerobic Exercises.

What condition does NCT04662021 study?

NCT04662021 studies Anxiety Depression Disorder.

Is NCT04662021 still recruiting?

NCT04662021 is currently status unknown. Last updated 11 January 2021.

Last reviewed 2021-01-11 · How we verify

NCT04662021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety

Status unknown NA Last updated 11 January 2021

What this trial tests

NA trial testing Aerobic Exercises in Anxiety Depression Disorder in 40 participants. Status unknown.

Timeline

10 December 2020

Primary endpoint
10 February 2021

25 February 2021

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	10 December 2020
Primary completion	10 February 2021
Estimated completion	25 February 2021
Sites	1 location across Egypt

Drugs / interventions tested

Aerobic Exercises

Conditions studied

Anxiety Depression Disorder — all drugs for Anxiety Depression Disorder →

Sponsor

Cairo University

Who can join

Adults 18 to 25, female only, with Anxiety Depression Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anxiety and depression disorders (ADD) have the highest overall prevalence rate among psychiatric disorders in young females. Its manifestations are disabling, distressing a substantial negative impact on the quality of life. The purpose of this study was to compare the effect of cognitive-behavioral therapy and physical therapy on female students with mild to moderate anxiety and depression.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues.
Mohapatra S, Ayash Kumar P, Farooq U, Jain P, et al · · 2022 · cited 3× · PMID 35645588 · DOI 10.1016/j.jsps.2022.05.004

Verify or expand the search:

Other trials of Aerobic Exercises

Trials testing the same drug.

NCT07076888 — Aerobic Exercises and Hemodialysis Patients · NA · recruiting
NCT06539793 — Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome · NA · recruiting
NCT06946758 — The Effects of Aerobic Exercise Combined With Core Stabilisation Training on Functional Capacity, Physical Performance a · NA · completed
NCT06479499 — Effects of Pilate Versus Aerobic Exercises on Dyspnea , Functional Capacity and Anxiety Status in Patients With COPD · NA · recruiting
NCT06479564 — Effects of Free Weight and Machine Training With and Without Aerobic Training Among Body Builders · NA · completed

Other recruiting trials for Anxiety Depression Disorder

Currently open trials in the same condition.

NCT07172607 — The Effect of Avnace eZZe on Sleep Improvement · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04662021 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 11 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04662021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing